ASX
Paradigm Biopharmaceuticals Limited
PAR:ASX•Healthcare
Sensitive ASX Announcement
PARs European Patent Granted for Bone Marrow Edema Lesions
Published: 16/01/18, 08:31am (AEST)•2 pages